NasdaqGS:OPKHealthcare
OPKO Health (OPK) Is Up 14.1% After Narrower Q2 Loss and New 2026 Revenue Guidance – Has The Bull Case Changed?
In late July 2026, OPKO Health, Inc. reported its second-quarter results, with revenue of US$163.58 million and a sharply reduced net loss of US$8.42 million, and issued new guidance calling for total revenue of US$131 million to US$142 million for the third quarter and US$560 million to US$585 million for full-year 2026.
While revenue for the first half of 2026 eased to US$287.78 million from US$306.76 million a year earlier, the company’s net loss contracted significantly over both the...